HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING
Brain · 2024
DOI: 10.1093/brain/awae053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Erliang Kong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Herpesvirus 1, Human, Membrane Proteins, Nucleotidyltransferases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Henan provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic varicella zoster virus (VZV) infection induced neuroinflammatory condition is the critical pathology of post-herpetic neuralgia (PHN). The immune escape mechanism of VZV remains elusive. As to mice have no VZV infection receptor, herpes simplex virus type 1 (HSV-1) infection is a well established PHN mice model. Transcriptional expression analysis identified that the protein arginine methyltransferases 6 (Prmt6) was upregulated upon HSV-1 infection, which was further confirmed by immunofluorescence staining in spinal dorsal horn. Prmt6 deficiency decreased HSV-1-induced neuroinflammation and PHN by enhancing antiviral innate immunity and decreasing HSV-1 load in vivo and in vitro. Overexpression of Prmt6 in microglia dampened antiviral innate immunity and increased HSV-1 load. Mechanistically, Prmt6 methylated and inactivated STING, resulting in reduced phosphorylation of TANK binding kinase-1 (TBK1) and interferon regulatory factor 3 (IRF3), diminished production of type I interferon (IFN-I) and antiviral innate immunity. Furthermore, intrathecal or intraperitoneal administration of the Prmt6 inhibitor EPZ020411 decreased HSV-1-induced neuroinflammation and PHN by enhancing antiviral innate immunity and decreasing HSV-1 load. Our findings revealed that HSV-1 escapes antiviral innate immunity and results in PHN by upregulating Prmt6 expression and inhibiting the cGAS-STING pathway, providing novel insights and a potential therapeutic target for PHN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Shanghai Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
- Department of Anesthesiology, The 988th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army, Zhengzhou, Henan 450042, China.
- Department of Histology and Embryology, Naval Medical University, Shanghai 200433, China.
Förderung
- National Natural Science Foundation of China
- Henan provincial Natural Science Foundation of China
Zitieren
APA
Kong, E., Hua, T., Li, J., Li, Y., Yang, M., Ding, R., Wang, H., Wei, H., Feng, X., Han, C., & Yuan, H. (2024). HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING. Brain. https://doi.org/10.1093/brain/awae053
Vancouver
Kong E, Hua T, Li J, Li Y, Yang M, Ding R, et al. HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING. Brain. 2024. doi:10.1093/brain/awae053
BibTeX
@article{Kong2024,
author = {Kong, Erliang and Hua, Tong and Li, Jian and Li, Yongchang and Yang, Mei and Ding, Ruifeng and Wang, Haowei and Wei, Huawei and Feng, Xudong and Han, Chaofeng and Yuan, Hongbin},
title = {HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awae053}
}
EUVIMED